In a report published Wednesday, Jefferies reiterated its Buy rating on Aetna AET, and raised its price target from $58.00 to $61.00.
Jefferies noted, “AET is our favorite Managed Care stock with 27% upside to our $61 price target (up from $58). Pro-forma for the CVH acquisition (close expected mid-2013), AET is the cheapest at 7.5x 2014E EPS. We believe the company's 2013 guidance is conservative, and that AET will deliver, if not exceed, the $0.45-0.90 EPS accretion guidance in 2014-15. This should enable AET to achieve a LT EPS CAGR in the low-to-mid teens.”
Aetna closed on Tuesday at $47.85.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in